Literature DB >> 21042772

N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal inflammation and tubulointerstitial fibrosis in rats.

Mingao Wang1, Ruichan Liu, Xibei Jia, Suhong Mu, Rujuan Xie.   

Abstract

It has been reported that N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) attenuates renal and cardiac inflammation as well as fibrosis in hypertensive rats. In this study, we investigated these effects using a unilateral ureteral obstruction (UUO) model. Eighteen male Wistar rats were randomly divided into three groups: control, UUO/vehicle and UUO/Ac-SDKP groups. Animal models of renal inflammation and tubulointerstitial fibrosis were established with unilateral ureteral ligation in rats. Ac-SDKP and vehicle were infused subcutaneously by using osmotic mini pumps for two weeks. On the 14th day post-injection, kidney histological changes of each group were observed by hematoxylin-eosin and Masson's stain. Renal macrophage infiltration, together with protein expression and localization of monocyte chemoattractant protein-1 (MCP-1), nuclear factor-kappa B (NF-κB), α-smooth muscle actin (α-SMA) and transforming growth factor-β1 (TGF-β1) in renal tissue was assessed by immunohistochemical staining. Gene expression of MCP-1 and TGF-β1 was analyzed with reverse transcription-polymerase chain reaction. Ac-SDKP-treated animals demonstrated less severe renal inflammation and tubulointerstitial fibrosis. Interstitial fibrosis was significantly attenuated with Ac-SDKP. ED-1 was expressed in the interstitium of the UUO/vehicle group kidneys and decreased with Ac-SDKP treatment. MCP-1, NF-κB, α-SMA and TGF-β1 were increased in the renal interstitium and tubular epithelial cells of the UUO/vehicle group. Ac-SDKP significantly reduced their expressions. Gene expressions of MCP-1 and TGF-β1 were upregulated in the UUO/vehicle group kidneys and were significantly inhibited by Ac-SDKP. In conclusion, in the rat UUO model Ac-SDKP administration protected against renal inflammation and tubulointerstitial fibrosis. The inhibitory effect of Ac-SDKP was mediated by the reduction in the expression of MCP-1, NF-κB, α-SMA and TGF-β1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21042772     DOI: 10.3892/ijmm_00000527

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  11 in total

1.  Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors.

Authors:  Megumi Kanasaki; Takako Nagai; Munehiro Kitada; Daisuke Koya; Keizo Kanasaki
Journal:  Fibrogenesis Tissue Repair       Date:  2011-11-30

Review 2.  N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes.

Authors:  Keizo Kanasaki; Takako Nagai; Kyoko Nitta; Munehiro Kitada; Daisuke Koya
Journal:  Front Pharmacol       Date:  2014-04-14       Impact factor: 5.810

3.  Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors.

Authors:  Ross G Douglas; Rajni K Sharma; Geoffrey Masuyer; Lizelle Lubbe; Ismael Zamora; K Ravi Acharya; Kelly Chibale; Edward D Sturrock
Journal:  Clin Sci (Lond)       Date:  2014-02       Impact factor: 6.124

4.  Therapeutic effects of human amniotic fluid-derived stem cells on renal interstitial fibrosis in a murine model of unilateral ureteral obstruction.

Authors:  Dong Sun; Lin Bu; Caixia Liu; Zhongcheng Yin; Xudong Zhou; Xiaoju Li; Aiguo Xiao
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

5.  Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme.

Authors:  Geoffrey Masuyer; Ross G Douglas; Edward D Sturrock; K Ravi Acharya
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

6.  N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice.

Authors:  Gary C W Chan; Wai Han Yiu; Hao Jia Wu; Dickson W L Wong; Miao Lin; Xiao Ru Huang; Hui Yao Lan; Sydney C W Tang
Journal:  Mediators Inflamm       Date:  2015-10-05       Impact factor: 4.711

Review 7.  The Effects of Angiotensin Converting Enzyme Inhibitors (ACE-I) on Human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Levels: A Systematic Review and Meta-Analysis.

Authors:  Ayanda Trevor Mnguni; Mark E Engel; Megan S Borkum; Bongani M Mayosi
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

8.  Acetylated α-Tubulin Regulated by N-Acetyl-Seryl-Aspartyl-Lysyl-Proline(Ac-SDKP) Exerts the Anti-fibrotic Effect in Rat Lung Fibrosis Induced by Silica.

Authors:  Wang Xiaojun; Liu Yan; Xu Hong; Zhang Xianghong; Li Shifeng; Xu Dingjie; Gao Xuemin; Zhang Lijuan; Zhang Bonan; Wei Zhongqiu; Wang Ruimin; Darrell Brann; Yang Fang
Journal:  Sci Rep       Date:  2016-08-31       Impact factor: 4.379

9.  Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.

Authors:  Enrico Conte; Evelina Fagone; Elisa Gili; Mary Fruciano; Maria Iemmolo; Maria Provvidenza Pistorio; Daniela Impellizzeri; Marika Cordaro; Salvatore Cuzzocrea; Carlo Vancheri
Journal:  Oncotarget       Date:  2016-06-07

10.  Upregulation of allograft inflammatory factor‑1 expression and secretion by macrophages stimulated with aldosterone promotes renal fibroblasts to a profibrotic phenotype.

Authors:  Yushu Li; Xingzhi Wang; Lei Zhang; Xueying Yuan; Jianbing Hao; Jie Ni; Lirong Hao
Journal:  Int J Mol Med       Date:  2018-05-10       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.